Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2539 | Next generation Sequencing (NGS) analysis Wiki | 1.00 |
| drug4729 | serum chemistry analysis Wiki | 1.00 |
| drug4724 | serological test Wiki | 1.00 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Translational, prospective / retrospective, non-profit, non-pharmacological study, with cohort characteristics. The study consists of two parts: the first to study epidemiological aspects of the spread of the disease and the second one to identify infection-related genetic factors.
Description: Investigate the epidemiology of the infection in an asymptomatic population including both healthy individuals at high risk of infection and oncological patients by assessing the seroprevalence of IgG and IgM antibodies against the SARS-CoV-2
Measure: epidemiology Time: 12 monthsDescription: IgG and IgM antibodies evaluation over time
Measure: Immunoglobulin G (IgG) and Immunoglobulin M (IgM) antibodies evaluation Time: 12 monthsDescription: Make a comparison between different serological investigation methods and rapid molecular methods becoming available
Measure: methods comparison Time: 24 monthsDescription: To evaluate correlation between biochemical and coagulative factors with SARS-CoV-2 positivity
Measure: correlation between biochemical and coagulative factors with SARS-CoV-2 positivity. Time: 24 monthsDescription: Building a phylogenetic map of an epidemic Italian macro-region
Measure: phylogenetic map Time: 24 monthsDescription: Evaluate the spectrum of possible interactions between the virus and host cells, considering their genetic variability / instability in patients diagnosed with COVID-19
Measure: interactions between the virus and host cells Time: 24 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports